About us

The Vaccine and Gene Therapy Institute (VGTI) at Oregon Health & Science University (OHSU) has assembled a multidisciplinary team of scientists to respond to serious viral disease threats, including AIDS, chronic viral infection-associated diseases, newly emerging viral diseases and infectious diseases of the elderly. Our Programs are intended to span the continuum between basic and clinical science, in which discoveries are rapidly advanced from the level of molecular and cellular biology through animal models and ultimately into clinical testing. Learn more

Upcoming seminars

Thursday October 19th, 2017 9:30am - VGTI Seminar Room
Topic: Zika Virus regulation of innate immunity through NF-kB antagon
Speaker: Jessica Smith, PhD
Research Assistant Professor, VGTI
Oregon Health and Science University

Thursday October 12th, 2017 9:30am - VGTI Seminar Room
Topic: KSHV manipulation of host iron homeostasis
Speaker: Jean Gustin, PhD
Assistant Staff Scientist, VGTI
Oregon Health and Science University

Thursday October 5th, 2017 9:30am - VGTI Seminar Room
Topic: Latent HCMV infection of CD34+ hematopoietic progenitor cells impairs myelopoiesis and stem cell engraftment in humanized BLT mice via up-regulation of TGFβ
Speaker: Lindsey Crawford, PhD
Assistant Staff Scientist, VGTI
Oregon Health and Science University

Thursday September 28th, 2017 9:30am - VGTI Seminar Room
Topic: HCMV miR-US22 Down-regulation of Egr-1 is Necessary for Viral Reactivation in CD34+ HPC
Speaker: Iliyana Mikel, PhD
Post-Doctoral Scholar, VGTI
Oregon Health and Science University